Brazilian federal government says 2 new national vaccines are advanced

One of these vaccines is a nasal spray, from USP; the other vaccine is developed at the Federal University of Minas Gerais

RIO DE JANEIRO, BRAZIL - Apart from ButanVac and Versamune, two more new Brazilian immunizers against Covid-19 are in advanced stages to request authorization from the National Health Regulatory Agency (ANVISA) to start clinical trials in the country.

Last week, ANVISA received requests for authorization for tests with two other national immunizers against the new coronavirus, ButanVac, and Versamune.

The information is from the Ministry of Science, Technology and Innovations' Research . . .

To read the full NEWS and much more, Subscribe to our Premium Membership Plan. Already Subscribed?